What Is GHB and How Poisoning Occurs
GHB, or gamma‑hydroxybutyric acid, is a central nervous system depressant that occurs naturally in the body and is also synthesized for illicit, medical, and industrial uses. GHB poisoning happens when a person ingests a quantity far above the threshold that the body can metabolize, leading to profound sedation, depressed breathing, and potentially death. Poisoning most often results from unintentional overdose, intentional high‑dose misuse, or consumption of illicit GHB of unknown concentration and purity. It can also follow unsafe handling or accidental ingestion in occupational settings.
Clinical Presentation and Recognizing Severe Poisoning
Physical and Neurological Signs
Early effects of GHB include euphoria, reduced inhibitions, dizziness, and drowsiness. As toxicity progresses, individuals may experience slurred speech, loss of coordination, unresponsiveness, and profound sedation. Respiratory depression is among the most serious signs, marked by slow, shallow breathing or gasping. Other symptoms include nausea, vomiting, bradycardia (slow heart rate), hypothermia, and cyanosis. Seizures and coma can occur in severe poisoning, especially when combined with other CNS depressants.
Differential Diagnosis and Mimickers
Because GHB acts on multiple neurotransmitter systems, its presentation can resemble intoxication from alcohol, benzodiazepines, opioids, or ketamine. Clinicians must consider polysubstance use, particularly when patients present with atypical features such as mixed agitation and sedation. Accurate history taking, observation of timing of symptom onset, and residual drug testing help distinguish GHB toxicity from other causes of depressed consciousness.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Common CNS Effects | Sedation, dizziness, euphoria, impaired motor coordination | Clinical toxicology literature |
| Respiratory Impact | Bradypnea, hypoventilation, risk of respiratory arrest | Case reports and pharmacokinetic studies |
| Timing of Onset | Oral onset in approximately 15–45 minutes; faster after injection | Pharmacology references |
| Duration of Action | Effects typically last 1–4 hours, but residual sedation possible | Clinical guidelines |
| Complications | Respiratory failure, aspiration, metabolic acidosis, rhabdomyolysis | Emergency medicine textbooks |
Immediate Management and Prehospital Care
Prehospital and First‑Responder Actions
When GHB poisoning is suspected, prioritize airway protection and breathing support. Place the patient in a recovery position if conscious but at risk of vomiting, and prepare for rapid transport. Continuous monitoring of oxygen saturation, respiratory rate, and level of consciousness is essential. Bag‑valve‑mask ventilation or advanced airway management may be required if hypoventilation or apnea develops. Emergency medical services should be activated immediately, and facilities with intensive care capabilities should be alerted en route.
Emergency Department Stabilization
In the ED, initial steps follow standard advanced cardiac life support and toxicology protocols: ensure adequate oxygenation and ventilation, obtain IV access, and monitor cardiac rhythm. Benzodiazepines may be used cautiously for agitation or seizures, but clinicians should avoid additional CNS depressants when possible. Because GHB is cleared renally and can cause significant sedation, careful observation for delayed deterioration is warranted, even after apparent recovery.
Pharmacology, Metabolism, and Toxicokinetics
GHB exerts effects primarily through GABA‑B receptor agonism, with secondary actions on dopamine release and neuronal excitability. After ingestion, it is absorbed quickly from the gastrointestinal tract, distributed into body water, and metabolized mainly in the liver and kidneys. Elimination half‑life varies but is commonly in the range of 30–90 minutes in healthy adults, though this can be prolonged in overdose, liver impairment, or when combined with other substances. These pharmacokinetic factors influence both the duration of toxicity and the potential for re‑sedation following initial improvement.
Risk Factors, Patterns of Use, and Public Health Context
Why Poisoning Events Occur
GHB poisoning is associated with several risk scenarios: unsupervised consumption of high‑potency illicit preparations, use of GHB as a date‑rape drug leading to accidental co‑ingestion with alcohol, recreational misuse in social settings, and deliberate self‑harm attempts. Body composition, tolerance, recent food intake, and concurrent use of other depressants all affect individual susceptibility. In some regions, GHB has appeared in emerging trends as a club drug or within product formulations that increase potency unpredictably.
Public Health and Prevention Strategies
Prevention focuses on education, harm reduction, and rapid recognition of overdose. Clinicians should counsel patients on the narrow therapeutic index of GHB and the dangers of combining it with other depressants. Public health messaging can highlight risks in nightlife contexts, emphasize the importance of never leaving drinks unattended, and encourage bystanders to seek immediate help if someone is unresponsive or breathing poorly. Facilities that provide testing for illicit substances may reduce harm by informing users about unexpectedly high concentrations.
When to Seek and Provide Emergency Care
Any suspected GHB overdose requires urgent medical evaluation. Warning signs that demand immediate activation of emergency services include unresponsiveness, slow or irregular breathing, pale or blue skin, choking or gurgling sounds, and prolonged sedation that does not improve. While awaiting EMS, keep the airway open, place the person in the recovery position if vomiting is possible, and avoid giving food or drink. Never leave the individual alone, and be prepared to provide accurate details about timing, suspected dose, and any other substances taken to emergency clinicians.
- Call emergency services immediately for severe symptoms such as apnea, cyanosis, or loss of consciousness.
- Support breathing and protect the airway; provide rescue ventilation if trained and necessary.
- Transport to a facility capable of advanced airway management and continuous monitoring.
- Inform clinicians about suspected GHB and any other drugs to guide testing and treatment.
- Follow up with healthcare providers for monitoring, especially if there was prolonged sedation or complications.
Conclusion and Key Takeaways
GHB poisoning is a medical emergency driven by excessive CNS and respiratory depression. Rapid recognition of symptoms, prompt airway and breathing support, and timely hospital care improve outcomes. Because GHB’s effects can recur as drug is cleared, prolonged observation is prudent. Public awareness, cautious handling of suspected illicit preparations, and coordination with health care professionals are essential components of prevention and response. Understanding the clinical profile, risks, and emergency steps helps clinicians and community members act effectively when GHB toxicity is suspected.